Explore
Novel Anticancer Strategies (Volume II)
0 Ungluers have
Faved this Work
Login to Fave
Novel Anticancer Strategies (Volume II) reviews important findings and updates within the cancer therapy field of great interest to those in academic research studying the development and validation of novel anticancer approaches. The Editor invited preeminent specialists to contribute to original and review articles devoted to key areas of major progress and expectations. Key Features:Nanoparticle-based drug delivery in cancer therapy;Nanoerythrosomes;Cancer immunotherapy;Therapeutic vaccines;Oncogenic and tumor suppressive components of the cell cycle;Antimitotics in cancer clinical trials;Multifunctional enzymes as anti-cancer drug targets;Targeting undruggable proteins and non-coding RNAs;Cell-penetrating peptides;Repurposed cancer drugs in clinical trials;Circulating tumour cells.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 38 times via unglue.it ebook links.
- 38 - pdf (CC BY) at Unglue.it.
Keywords
- 4-borono-l-phenylalanine
- active targeting
- adrenocortical carcinoma
- agarose
- Angiogenesis
- antibody functionalization
- anticancer target
- antimitotics
- Apoptosis
- BAX
- BI2536
- biomimetic
- boron neutron capture therapy
- Breast cancer
- breast cancer treatment
- BUB3
- Cancer
- cancer stem cells
- cancer theranostic
- cancer therapy
- cathepsins
- Cell Cycle
- Cell-Penetrating Peptides
- chemotherapy
- chemotherapy resistance
- CHRNA5
- cisplatin
- Clinical & internal medicine
- clinical translation
- clinical trials
- collagen
- combinational immunotherapy
- comparative oncology
- controlled drug release
- COVID-19
- CTCs
- curcumin
- cyclin-dependent kinase
- Cytotoxicity
- Diagnostics
- Diseases & disorders
- dog
- Drug delivery
- Drug Discovery
- drug repurposing
- electrospun nanofibers
- enhanced permeation and retention effect
- Flavonoids
- gemcitabine
- gold nanorods
- HCC
- HL60
- HPMA
- hydrogel
- Hyperthermia
- imaging agents
- immune checkpoint
- Immunotherapy
- inorganic nanoparticles
- iron oxide nanoparticles
- laser medical applications
- Leukemia
- lung cancer
- mammary spheroids
- mebendazole
- medicine
- melanin nanoparticles
- Melanoma
- mesoporous silica nanoparticles
- metallodrugs
- metastases
- metastasis
- metastasis suppression
- miRNA
- mitosis
- mitotic slippage
- molecular targets
- molecular-targeted therapies
- MOMP
- multi-drug resistance
- multifunctional enzymes
- n/a
- nanocarrier
- nanoerythrocyte
- nanoerythrosome
- nanotherapeutics
- nanovesicles
- Navitoclax
- neoantigens
- new anti-cancer drugs
- non-coding RNAs
- NSCLCs
- oligonucleotide therapeutics
- on-demand drug delivery systems
- oncology
- oncomiRs
- p16
- p21
- p27
- paclitaxel
- Pandemic
- Patched
- PD-1
- persistent cells
- phosphino-amine ligands
- photodynamic therapy
- photodynamic therapy PDT
- PLK1
- poly (N-isopropylacrylamide)
- polymer
- porphyrin
- precision medicine
- prodrug
- prognosis
- protein transduction domains
- RAPTA derivatives
- Resistance
- Retinoic acid
- senescence
- slippage
- solubility
- sorafenib sensitivity
- spheroids
- spindle assembly checkpoint
- SPIONs
- stemness property
- targeted drug delivery systems
- targeted therapies
- Tissue Engineering
- TNBC
- TRAIL
- TRAIL resistance
- Tumor imaging
- tumoroids
- Ubiquitination
- undruggable targets
- vaccination
- Vaccine
- vitamin K
- β-cyclodextrin
Links
DOI: 10.3390/books978-3-0365-7032-7Editions